PROPANC BIOPHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2022
Total Assets: $81.7K
Liabilities Breakdown FY2022
Total Liabilities: $3.1M
Asset Breakdown
Total Assets: $81.7K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.1K | 5.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.0K | 2.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $75.6K | 92.5% |
Liabilities Breakdown
Total Liabilities: $3.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $943.0K | 30.4% |
| Long-Term Debt | $926.4K | 29.8% |
| Other Liabilities | $1.2M | 39.8% |